米兰体育

Skip to content
NOWCAST 米兰体育 13 6am Newscast
Watch on Demand
Advertisement

Do I need a booster if I got the Johnson & Johnson vaccine?

Do I need a booster if I got the Johnson & Johnson vaccine?
GOING TO SAY, YOU KNOW WHAT? CHICAGO HAS NO CASES OF COVID TODAY. SOLEDAD: THOSE GOING DOOR-TO-DOOR ENCOUNTER A RGEAN OF PEOPLE AT THE DOOR, FROM ETH COVID DENIERS OR JUST THE UNCERTN.AI DR. LAURA MURRAY IS A CLINICAL PSYCHOLOGIST AND A SENIOR SCIENTIST AT JOHNS HOPKINS UNIVERSITY SCHOOL OF PUBCLI HEALTH. SHE鈥橲 AN EXPERT ON BEHAVIORA HEALTHSSS. I DR. LAURA MURRAY, THANK YOU FOR JOINING ME. GIVE ME A SENSE OF WHAT鈥橲 DRIVING THAT 40% OF PEOPLE WHO ARE JUST NOT VACCINATED AND DON鈥橳 SEEM TO WANT TO BE VACCINATED DR. MURRAY: SO, WE鈥橰E HEARING NOT ENOUGH INFORMATION, WORRIES ABOUT POSSIBLE SIDE EFFECTS, DISTRUSTN IGOVERNMENT TO MAKE SURE THAT VACCINES ARE SAFE AND EFFECTIV POLITICS HAVE PLAYED A ROLE. THE BELIEF THAT THE RISK OF COVID MAY BE EXAGGEREDAT IS SOMETHING WE鈥橰E HEARING. SOLEDAD: THIS IDEA, LIKEI, DON鈥橳 KNOW ENOUGH ABOUT THE VACCINE. WHERE DOES THAT COME FROM? IS THAT MISINFORMATION? DR. MURRAY: IN GENERAL, TSEHO THAT ARE HESITANT HAVE A PSYCHOLOGICAL VARIABLE THAT HAS A LOWER LEVEL OF TRUSTN I SCIENTISTS, HEALTH CARE PROFESSIONALS AND STATE LIKELY, NOT SURPRISING. THEY TEND TO HAVE LOWER LELSVE SOFOMETHING WE CALL COGNITIVE REFLECTION OR JUST LOWER LEVELS OF THINKING THROH UGSOMETHING VERY CAREFULLY. THEY TEND TO HAVE LOWER LEVELS OF ALTRUISM. CONSPIRATORIAL THINKINISG ANOTHER PREDICTOR OF VACCINE HETASINCY. WE鈥橰E SEEING A PSYCHOLOGICAL VARIABLE WHERE THESE FOLKS ARE HAVING HIGHER LEVELS OF AN INTERNAL LOCUS OF CONTROL. AND WHAT THAT MEANS IS THEY LIKE TO HAVE MORE CONTROL, WHICH MAY GUIDE THE NEED TO HA MVEORE OF THAT INFORMATION. SOLEDAD: KNOWING ALL OF THAT THEN AND KNOWINGHE PSYCHOLOGICAL PROFILE, HOW DO YOU USE THAT TO GET THAT0% 4 VACCINATED? DR. MURRAY: ONE OF THE THINGS WE TALK ABOUT WHILE WORKINGN O HUMAN BEHAVIOR CHANGE IS TAKGIN SOME OF THE EMOTION OUT OF IT, AND THIS IS SO MUCH EASIER SAID THAN DONE BECAUSE A LOT OFS U WHO ARE REACHING OUT FEEAL CERTAIN WAY OUELRSVES. ANOTHER SOLUTION IS TO ASK A LOT OF QUESTIONS. WHAT WOULD THESE PEOPLE NEED TO KNOW TO CONSIDER THE VACNECI RATHER THAN JUST FEEDING WHAT WE MIGHT COME UP WITH? WE KNOW THAT MESSAGING IS OFTEN BEST WHEN IT鈥橲 SOMEONE WHO鈥橲 TRUSTED. AND I KNOW DIFFERE CNTOMMUNITIES AND GOVERNMENTS ARE USING SOCIAL INFLUENCERS OR COMMUNITY LEADERS TO REACH THOSE THAT ARE VACCINE HESITANT AT A NEIGHBHOOROD LEL.VE RESEARCH SHOWS THAT POSITIVE EMOTIONAL MESSAGES SUCH AS ALTRUISM AND HOPE ARE ACTUALLY MORE EFFECTIVE THAN NEGATIVE ONES OR FORCING PEOPLE. AND, SOLEDAD, YOU BROUGHT UP FOR THOSE THAT ARE STRONGLY OPPODSE TO VACCINES JUST BASED ON EMOTION OR IDEOLOGY, MORALS, IT鈥橲 VERY, VERY CHALLENGINGO T OVERRIDE THEM WITH FACTSND A INFORMATION, JUST FROM A HUMAN BEHAVIOR CHANGE PERSPECTIVE. SO, WE REALLY NEED TO WO ONRK DIFFERENT MESSAGING FOR THEES GROUPS, MAYBE ALMOST CHARACTERIZE IT AS A RIGHTR O PRIVILEGE THAT THEY SHOULDN'鈥� LET OTHERS TAKE AWAY FROM TH.EM SOLEDAD: DR. LAURA MURRAY WITH JOHNS HOPKINS UNIVERSITY, TH
Advertisement
Do I need a booster if I got the Johnson & Johnson vaccine?
Related video above: The Psychology Behind Vaccine HesitancyDo I need a booster if I got the Johnson & Johnson vaccine?Probably at some point, but health officials still are collecting the data needed to decide. With boosters being planned in the U.S. as early as the fall for those who got the two-shot Pfizer and Moderna vaccines, recipients of the single-dose J&J jab might be wondering just how well their protection is holding up.All the vaccines used in the U.S. 鈥� including the J&J vaccine 鈥� still are doing their job of preventing hospitalizations and deaths from COVID-19."I don't think there's any signal that the J&J vaccine is failing at its primary task," said Dr. Amesh Adalja, an infectious disease specialist at the Johns Hopkins Bloomberg School of Public Health.Despite continued protection against severe disease, U.S. officials are planning to offer Pfizer and Moderna boosters eight months after the second shot based on evidence that effectiveness against infection wanes over time. Adding to the decision, the vaccines don't appear quite as strong against the highly contagious delta variant as they were against earlier versions of the virus.U.S. Surgeon General Vivek Murthy said boosters "will likely be needed" for the J&J vaccine. Authorities expect more data to decide in the coming weeks.That's in part because the J&J rollout didn't start until March, several months after Pfizer and Moderna vaccinations began. The J&J shot is made differently. And there's more data about how the Pfizer and Moderna vaccines fare against delta because they're more widely used in countries where the variant struck before its U.S. surge.There is some real-world data showing J&J's shot holds up against the delta variant. A huge study of health workers in South Africa showed the vaccine remains highly effective against hospitalizations and death from the variant. And the vast majority of so-called "breakthrough" infections in vaccinated people were mild.J&J has also presented lab data on virus-fighting antibodies that indicates its vaccine protects against the delta variant for eight months and counting. Another small lab study has raised questions about whether a two-dose approach would work better, an option J&J is studying.A separate issue is whether people with severely weakened immune systems should get extra shots as part of their original vaccinations, since they don't respond as well to any vaccines. The government now recommends a third shot of the Pfizer or Moderna vaccines for organ transplant recipients and others in this group. But it's still collecting data before making a similar recommendation for another dose of the J&J vaccine.

Related video above: The Psychology Behind Vaccine Hesitancy

Do I need a booster if I got the Johnson & Johnson vaccine?

Advertisement

Probably at some point, but health officials still are collecting the data needed to decide.

With boosters being planned in the U.S. as early as the fall for those who got the two-shot Pfizer and Moderna vaccines, recipients of the single-dose J&J jab might be wondering just how well their protection is holding up.

All the vaccines used in the U.S. 鈥� including the J&J vaccine 鈥� still are doing their job of preventing hospitalizations and deaths from COVID-19.

"I don't think there's any signal that the J&J vaccine is failing at its primary task," said Dr. Amesh Adalja, an infectious disease specialist at the Johns Hopkins Bloomberg School of Public Health.

Despite continued protection against severe disease, U.S. officials are planning to offer Pfizer and Moderna boosters eight months after the second shot based on evidence that effectiveness against infection wanes over time. Adding to the decision, the vaccines don't appear quite as strong against the highly contagious delta variant as they were against earlier versions of the virus.

U.S. Surgeon General Vivek Murthy said boosters "will likely be needed" for the J&J vaccine. Authorities expect more data to decide in the coming weeks.

That's in part because the J&J rollout didn't start until March, several months after Pfizer and Moderna vaccinations began. The J&J shot is made differently. And there's more data about how the Pfizer and Moderna vaccines fare against delta because they're more widely used in countries where the variant struck before its U.S. surge.

There is some real-world data showing J&J's shot holds up against the delta variant. A huge study of health workers in South Africa showed the vaccine remains highly effective against hospitalizations and death from the variant. And the vast majority of so-called "breakthrough" infections in vaccinated people were mild.

J&J has also presented lab data on virus-fighting antibodies that indicates its vaccine protects against the delta variant for eight months and counting. Another small lab study has raised questions about whether a two-dose approach would work better, an option J&J is studying.

A separate issue is whether people with severely weakened immune systems should get extra shots as part of their original vaccinations, since they don't respond as well to any vaccines. The government now recommends a third shot of the Pfizer or Moderna vaccines for organ transplant recipients and others in this group. But it's still collecting data before making a similar recommendation for another dose of the J&J vaccine.